{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:45Z","timestamp":1746417765212,"version":"3.40.4"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hyperammonemia encephalopathy is a rare but severe complication that has been reported in association with the use of sunitinib, a tyrosine kinase inhibitor. We report here a unique case of a patient with end stage renal disease that was initiated on sunitinib for metastatic renal cell carcinoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 65-year-old man with end stage renal disease on maintenance conventional hemodialysis and had concomitant stable Child-Pugh class B liver cirrhosis consequent of hepatitis C infection was started on sunitinib for metastatic renal cell carcinoma. He developed confusion few weeks after starting therapy with no other indication of worsening liver dysfunction otherwise.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>He was later diagnosed with hyperammonemia encephalopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>His treatment was discontinued and reinitiated at a lower dose after recovery and titrated according to tolerance. As ammonia is a very low molecular weight molecule and is cleared well with diffusive clearance, we intensified his dialysis regimen by increasing intensity for each session and frequency per week.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>With this change in dialysis regimen, patient was able to continue treatment with sunitinib.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Clinicians prescribing sunitinib should be vigilant to monitor for this complication in patients receiving sunitinib, apart from the more usual presentation of hepatotoxicity. We found that a more intensive hemodialysis regimen consisting of 4\u00d7 a week conventional high-flux hemodialysis (HD) can permit the continuation of treatment with sunitinib in an end stage renal disease (ESRD) patient with Child-Pugh class B liver cirrhosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024313","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T19:36:21Z","timestamp":1614108981000},"page":"e24313","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Sunitinib-associated hyperammonemic encephalopathy successfully managed with higher intensity conventional hemodialysis"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-0065","authenticated-orcid":false,"given":"Sabrina","family":"Haroon","sequence":"first","affiliation":[{"name":"Division of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Advanced Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alvin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poh-Seng","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, National University Hospital Singapore, Republic of Singapore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Titus","family":"Lau","sequence":"additional","affiliation":[{"name":"Division of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/iju.13759","article-title":"Renal tumors in end-stage renal disease: a comprehensive review","volume":"25","author":"Tsuzuki","year":"2018","journal-title":"Int J Urol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"11579","DOI":"10.1073\/pnas.1816012116","article-title":"My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer","volume":"116","author":"Levitzki","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Escudier","year":"2019","journal-title":"Ann Oncol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.clinthera.2007.07.022","article-title":"Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors","volume":"29","author":"Adams","year":"2007","journal-title":"Clin Ther"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1478-3231.2010.02302.x","article-title":"Interorgan ammonia metabolism in liver failure: the basis of current and future therapies","volume":"31","author":"Wright","year":"2011","journal-title":"Liver Int"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cld.2015.05.002","article-title":"Ammonia and its role in the pathogenesis of hepatic encephalopathy","volume":"19","author":"Parekh","year":"2015","journal-title":"Clin Liver Dis"},{"key":"R8-20250504","first-page":"S0735-6747(20)30674-4","article-title":"Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors","author":"Lee","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12054","article-title":"Sunitinib-induced hyperammonaemia in a patient with pancreatic neuroendocrine tumour","volume":"38","author":"Shea","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.jpainsymman.2014.01.002","article-title":"Acute hyperammonemic encephalopathy in a non-cirrhotic patient with hepatocellular carcinoma reversed by arginine therapy","volume":"47","author":"Shinde","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1097\/MJT.0b013e3182a32e0e","article-title":"A rare case of sunitinib-induced hyperammonemic encephalopathy and hypothyroidism in metastatic renal cell carcinoma","volume":"23","author":"Pilanc","year":"2016","journal-title":"Am J Ther"},{"key":"R12-20250504","first-page":"S0735","article-title":"Sunitinib-associated hyperammonemic encephalopathy","volume":"10","author":"Lipe","year":"2020","journal-title":"Am J Emerg Med"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2215\/CJN.01320216","article-title":"The role of RRT in hyperammonemic patients","volume":"11","author":"Gupta","year":"2016","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:14:00Z","timestamp":1746339240000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024313"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024313","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"2020-10-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}